Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $164 Billion
- Q4 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,026,588 shares of ARCT stock, worth $14.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,026,588
Previous 1,947,835
4.04%
Holding current value
$14.7 Million
Previous $35.9 Million
58.96%
% of portfolio
0.01%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding ARCT
# of Institutions
170Shares Held
26.2MCall Options Held
2.21MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.87MShares$13.6 Million0.24% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...